Expand your HIV Toolkit: Cabotegravir and Rilpivirine (CAB/RPV) Essentials and Clinical Guide

This resource is to inform healthcare providers about CAB/RPV, the first FDA-approved long-acting injectable antiretroviral (ARV) medication for patients with HIV. The comprehensive toolkit includes recommendations for patient evaluation, screening, and shared decision making when considering prescribing CAB/RPV. It also includes implementation tools such as sample checklists, protocols, and resources available to aid in the implementation of offering CAB/RVP in healthcare settings.